Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X. (2015)
Attributed to:
Expansion of MRCTs Drug Discovery Group (DDG)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/srep17338
PubMed Identifier: 26626428
Publication URI: http://europepmc.org/abstract/MED/26626428
Type: Journal Article/Review
Volume: 5
Parent Publication: Scientific reports
ISSN: 2045-2322